Michelle Trachtman is the Executive Director of the Mike Shane Memorial Fund (MSMF) a nonprofit fund that provides grants to patients with Cholangiocarcinoma for remote second opinions. After spending more than a decade dedicating her time to several different non-profits, Michelle knows what’s truly important when running a charity. The cornerstones of how she leads MSMF are integrity, transparency and excellence.
Michelle became interested in second opinions when one saved the life of a close family member. This made connecting patients with expert medical providers her passion.
Michelle’s career started in the healthcare field as a Speech and Language Pathologist working in rehabilitation hospitals, until retiring to raise her children. While a stay-at-home mom, Michelle was drawn to help others which launched her “career” as a volunteer. She served on various committees at several organizations on the Executive Board of the Children’s Cancer Foundation (Maryland).
Michelle holds a Bachelor of Arts in Teacher of the Speech and Hearing Handicapped from Hofstra University, and an Master of Arts from Northwestern University in Speech/Language Pathology. She is a mother of two adult children and lives in Crownsville, Maryland with her husband Les and their dog, Tucker.
Board of Directors
Rocky was the founder and owner of Force 3, Inc, a Federal Information Technology company based in the Washington, DC metro area. The company, founded in 1991, had more than 400 employees and revenue of more than $300 million when it was sold in 2016 to Sirius, Inc., a multi-billion dollar IT firm out of San Antonio, Texas. The company won numerous awards and by 1998 had become the largest minority owned 8(a) Government contractor in the country. Rocky has served on numerous boards and currently is on The Board of Advisors at The University of Maryland, Smith School of Business, his alma mater. Currently he is the Managing Director of Shoreham Investments, LLC., an investment company focused on healthcare, emerging technologies and real estate in The United States and Mexico. He has a wife, 3 children and is an avid surfer and golfer.
Deepak Hathiramani is the Co-Founder and Executive Chairman of SteeleHarbour Capital Partners, a real estate investment management firm focused on middle-market strategic equity, preferred equity and debt investments with a primary focus on multifamily and office properties in high growth markets in the Southeast and Mid-Atlantic United States.
Prior to SteeleHarbour, Mr. Hathiramani was the founder of Vistronix Intelligence and Technology Solutions, a national security solutions provider until its recent acquisition by Arctic Slope Regional Corporation (ASRC) Federal Holding Company in August 2016. In the past, Mr. Hathiramani served as the Chairman, Chief Executive Officer and president of Vistronix and was a member of the Audit and Compensation Committee.
Mr. Hathiramani has more than 25 years of experience with privately funded and venture-funded high- tech start-ups. Prior to Vistronix, he worked with high-tech start-ups including Nx Networks (Netrix Corporation) through its Initial Public Offering and Cinnabar Software until its acquisition by publically traded KMW Systems.
Mr. Hathiramani received a B.A., Cum Laude from the University of Texas at Austin and a B.S. (Honors) from the University of Bombay, India. He possesses a Diploma in Business Management and Industrial Administration and has completed several Business Executive Programs from the Amos Tuck School, Dartmouth College. Mr. Hathiramani most recently completed a Certificate Program in Walkable Urban Real Estate Development at the George Washington University.
Mr. Hathiramani serves on the Advisory Board of Blue Delta Capital Partners, Aanika Bioscience, Mike Shane Memorial Fund and several government contractors. He is a member of George Mason University’s Volgenau School of Engineering Advisory Board, the University of Texas at Austin Department of Computer Science Advisory Council and the Northern Virginia Technology Council (NVTC) Senior Advisory Board. Mr. Hathiramani also served as a past member of the Executive Committee and Board of Directors of the Professional Services Council (PSC).
Lisa was diagnosed in 2010 with Stage IV Intrahepatic Cholangiocarcinoma and given six months to live. Searching out a second opinion from a multidisciplinary team at The Cleveland Clinic, she found hope and direction. Dr. John Fung performed two successful liver resections and lead Lisa's team through both surgeries, over 50 chemotherapy treatments with four different agents and SBRT three times. Lisa has endured 5 recurrences with 8 tumors and now is currently NED. Through Lisa's journey, she has learned that her passion is to help others navigate their treatment journey as a patient advocate, offering love, hope and support to other survivors. Lisa serves others through many organizations including, The Scott Hamilton Cares Initiative, Imerman's Angels, Research Advocate Network, Girls on the Run, Cleveland Clinic Voice of the Patient Advocacy Council, The Global Liver Institute, BagIt, Target Cancer and The Cholangiocarcinoma Foundation.
Lisa spends her days mentoring patients, advocating for new treatments and raising research money through Craine's Cholangiocarcinoma Crew.
Lisa has a BA in Communications and a BFA in Musical Theatre from Kent State University. She lives in Ohio with her husband, David and sons, Jacob and Noah.